AQST
NASDAQ · Pharmaceuticals
Aquestive Therapeutics Inc
$4.32
+0.09 (+2.13%)
Open$4.25
Previous Close$4.23
Day High$4.36
Day Low$4.25
52W High$7.55
52W Low$2.12
Volume—
Avg Volume1.13M
Market Cap536.91M
P/E Ratio—
EPS$-0.78
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+499.5% upside
Current
$4.32
$4.32
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 53.26M | 54.48M | 128.94M |
| Net Income | -100,171,916 | -92,220,462 | 33.13M |
| Profit Margin | -188.1% | -178.7% | 25.7% |
| EBITDA | -91,146,728 | -88,573,436 | 53.66M |
| Free Cash Flow | — | — | 23.71M |
| Rev Growth | -2.2% | -2.2% | +19.1% |
| Debt/Equity | 4.68 | 4.68 | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |